Since 1998, the US FDA has approved 3 drugs for brain cancer, 10 for lung cancer and 7 for melanoma. However, for brain cancer, 75 drugs failed in development, 167 therapies for lung cancer failed in clinical trials, and 96 drugs for melanoma failed in development. Presently, in the US, 47 new therapies for brain […]
According to the US EPA’s Office of Inspector General (OIG), approximately 300 chemicals considered by the Resource Conservation and Recovery Act to be hazardous are unregulated. The Clean Water Act allows the EPA to regulate any substances, but the agency applies the rule to only 126 priority chemicals. Although industrial polluters are required to report […]
A summary of biopharmaceutical approvals in the US and UK from January 2010 to July 2014 showed that 54 products were approved. Drugs new to the market accounted for 59% of the therapies (32), with the remaining biologics being biosimilars, reformulated and me-too drugs, and products that previously had been approved elsewhere. Of the 32 […]
For the second quarter, revenues for IBO’s Lab Equipment/Consumables Index grew 4.1%, 4.0% excluding currency, to $4,278 million. Operating profit for the Index rose 7.6% to $794 million. Based on continuing operations, operating margin gained 50 basis points to 16.5% of sales. Second quarter sales benefited from delayed orders in the first quarter due to […]
Hong Kong 10/9/14; Singapore 10/9/14—Techcomp has agreed to acquire from Bruker the assets related to Bruker’s GC and single-quadrupole GC/MS businesses, including inventories, intellectual property, trademark, licenses and other assets, for $13.5 million. The net book value of the tangible assets is $14 million. Techcomp stated that the acquisition will allow it to expand its […]
Pleasanton, CA 10/9/14—Roche has acquired exclusive rights to target-discovery company AbVitro’s primer-extension–based target-enrichment (PETE) technology and associated patent applications. Financial details were not disclosed. PETE technology will be used to support Roche’s next-generation sequencing (NGS) directly from blood or other biological samples. The technology will be incorporated into the Sequencing Unit’s R&D pipeline to support […]
Chelmsford, MA 10/1/14—Brooks Automation, a provider of automation and cryogenic solutions, has acquired UK-based FluidX for $16 million. FluidX is a supplier of biological-sample storage tubes and complementary benchtop instruments. In 2013, FluidX generated $10 million in sales. “FluidX is an important building block for Brooks Life Science Systems, bringing state-of-the-art biological-sample storage consumables into […]
Franklin Lakes, NJ 10/13/14—Becton, Dickinson and Company (BD) has acquired GenCell Biosystems for an undisclosed amount. Founded in 2011 and based in Ireland with an office in the US, GenCell provides technology for biological-analysis protocols, including library preparation for next-generation sequencing (NGS) and genotyping for agricultural applications. “We are excited with the GenCell Biosystems acquisition […]
Austin, Texas 10/15/14—Luminex has announced the retirement of President and CEO Patrick J. Balthrop. The company named Nachum “Homi” Shamir as the new president and CEO. Most recently, he served as president and CEO of Given Imaging. “Mr. Shamir brings a proven track record of global leadership and results,” stated Board Chairman Wally Loewenbaum. Mr. […]
Radnor, PA 10/1/14; New York, NY 10/2/14; Washington, DC 10/3/14—On October 2, laboratory-product provider VWR began publicly trading its stock on the NASDAQ (see IBO 9/30/14) at a price of $21 per share, raising $536 million. The company also granted the underwriters a 30-day option to purchase 3.8 million shares. Proceeds from the offering are […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
